Morgan Stanley (MS) 13D/13G Filings for Rigel Pharmaceuticals, Inc. (RIGL)

Morgan Stanley 13D and 13G filings for Rigel Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-07
4:15 pm
Sale
2025-09-3013GRIGEL PHARMACEUTICALS INC
RIGL
MORGAN STANLEY
MS
116,406
0.700%
-1,332,654decrease
(-91.97%)
Filing